Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHK-Cu

Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper, Prezatide Copper

Quick Stats
Studies 149
Trials 1
Score 3
2021 pubmed

Tripeptide/Hexapeptide Topical in Esthetics: Evidence behind the Skincare Formulation.

Wang. Jordan V JV; Hattier. Georgette G; Saedi. Nazanin N

Key Findings

  • Topical GHK‑Cu improves wound healing and reduces recovery time after skin resurfacing procedures.
  • Combining the tripeptide with a hexapeptide enhances the cosmetic results of cryolipolysis (fat‑freezing) treatments.
  • Both peptides show modest benefits for overall skin rejuvenation, such as increased collagen density and smoother texture.

Practical Outcomes

  • For biohackers interested in skin health, using a serum containing GHK‑Cu (often 0.5–1 % concentration) after aesthetic procedures may speed recovery and improve results. It can also be added to a daily skincare routine for modest anti‑aging benefits, though precise dosing and long‑term safety still need more research.

Summary

The paper reviews evidence that a copper‑bound tripeptide (GHK‑Cu) and a related hexapeptide, when applied to the skin, can speed up healing after procedures like laser resurfacing or fat‑freezing (cryolipolysis) and help make the skin look younger. The data come from several small studies and suggest the peptides boost collagen and reduce inflammation, but the review doesn’t present brand‑new experiments or exact dosing guidelines.

Abstract

The skincare market, which is projected to be worth over $180 billion by 2024, has experienced a recent rise in formulations utilizing peptides. These products have been marketed to consumers as offering many esthetic benefits. We review the literature for a tripeptide and hexapeptide formulation that has been shown to offer improved healing and clinical outcomes in conjunction with resurfacing and cryolipolysis, as well as demonstrating benefit for cutaneous rejuvenation.

Study Information

Provider

pubmed

Year

2021

Date

2021-04-01T00:00:00.000Z